Dr. Arun Menawat
Chief Executive Officer and Chairman
Replay available
Profound Medical Corp. (PROF) Q2 2026 Earnings Call
Profound Medical Corp. (NASDAQ: PROF) Q2 2026 earnings conference call, held 2026-08-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Stephen Kilmer
Investor Relations
Mathieu Sobczyk
Corporate Controller
Dr. Mathieu Burtnyk
President
Tom Tamberrino
Chief Commercial Officer
Ben Hainer
Lake Street Capital Markets Analyst
Michael Freeman
Raymond James Analyst
Kyle Bowser
Titan Partners Analyst
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Profound Medical Corp.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.113 Good day and thank you for standing by. Welcome to Profound Medical's second quarter 00:00:05.113 -- 00:00:10.756 2026 financial results conference call. At this time, all participants 00:00:10.756 -- 00:00:15.558 are in listen-only mode. After the speaker's presentation, there will be a question and 00:00:15.558 -- 00:00:20.600 answer session. To ask a question during the session, you will need to press star 00:00:20.600 -- 00:00:25.702 1-1 on your telephone. You will then hear an automated message advising your hand is 00:00:25.702 -- 00:00:30.978 raised. To withdraw your question, please press star 11 again. 00:00:30.978 -- 00:00:35.759 Please be advised that today's conference is being recorded. 00:00:36.000 -- 00:00:40.882 I would now like to hand the conference over to your first speaker today, Stephen Kilmer, 00:00:40.882 -- 00:00:43.322 Investor Relations. 00:00:46.224 -- 00:00:48.684 Thank you. Good afternoon, everyone. 00:00:48.684 -- 00:00:53.006 Let me start by pointing out that this conference call will include forward-looking statements 00:00:53.006 -- 00:00:57.610 within the meaning of applicable securities laws in the United States and Canada. 00:00:57.610 -- 00:01:01.052 All forward-looking statements are based on Profound's current beliefs, assumptions, 00:01:01.052 -- 00:01:05.875 and expectations and relate to, among other things, any expressed or implied statements 00:01:05.875 -- 00:01:10.798 or guidance regarding current or future financial performance and position and expectations 00:01:10.798 -- 00:01:13.860 regarding the efficacy of Profound's technology. 00:01:13.860 -- 00:01:18.842 Such statements involve known risks and uncertainties and other factors that may cause 00:01:18.842 -- 00:01:22.985 actual r...